[
  {
    "ts": null,
    "headline": "Amneal Receives U.S. FDA Approval for Iohexol Injection",
    "summary": "First-to-market complex injectable with expected launch in Q1 2026BRIDGEWATER, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced the U.S. Food and Drug Administration (FDA) has approved the Company’s iohexol injection (300 mg Iodine/mL), the first generic version of GE Healthcare’s Omnipaque® (iohexol) injection. Amneal expects to launch the product in the first quarter of 2026. Iohexol is a radiographic contrast agent",
    "url": "https://finnhub.io/api/news?id=eb4051cb27e70de307f405889bd49546b11a0386a2fd71a87dc3331b2040733f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763067660,
      "headline": "Amneal Receives U.S. FDA Approval for Iohexol Injection",
      "id": 137477123,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GEHC",
      "source": "Yahoo",
      "summary": "First-to-market complex injectable with expected launch in Q1 2026BRIDGEWATER, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced the U.S. Food and Drug Administration (FDA) has approved the Company’s iohexol injection (300 mg Iodine/mL), the first generic version of GE Healthcare’s Omnipaque® (iohexol) injection. Amneal expects to launch the product in the first quarter of 2026. Iohexol is a radiographic contrast agent",
      "url": "https://finnhub.io/api/news?id=eb4051cb27e70de307f405889bd49546b11a0386a2fd71a87dc3331b2040733f"
    }
  },
  {
    "ts": null,
    "headline": "Why GE HealthCare Technologies (GEHC) is a Top Value Stock for the Long-Term",
    "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
    "url": "https://finnhub.io/api/news?id=3a9049074d44ca7851b735da7a905862215a7618f1d7786a5448b63657316800",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763044803,
      "headline": "Why GE HealthCare Technologies (GEHC) is a Top Value Stock for the Long-Term",
      "id": 137469347,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GEHC",
      "source": "Yahoo",
      "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
      "url": "https://finnhub.io/api/news?id=3a9049074d44ca7851b735da7a905862215a7618f1d7786a5448b63657316800"
    }
  }
]